Literature DB >> 20653541

Green tea extract-patents and diversity of uses.

Samuel T Saito1, Grace Gosmann, Cristina Pungartnik, Martin Brendel.   

Abstract

Green tea is one of the most consumed beverages in the world. Presently, Camellia sinensis has become a source not only for the development of several food extracts but also nutraceutical, cosmetic and medicinal purposes. The technology developed to produce these extracts aims to improve the organoleptic characteristics of the products as taste and smell, and their shelf life. But it also searches to demonstrate some medicinal attributes like antioxidant, anti-aging, anti-tumor and anti-viral activities in relation to the chemical composition of the green tea catechins, especially (-)-epigallocatechin gallate (EGCG). The target of this review is to present the various patents related to the extraction methods and their claims, and to discuss the evidence found in the literature about the pharmacological activities of green tea. It summarizes the recent progress in technology to obtain the green tea extract and in clinical studies on its applications. Health-promoting products and disease-preventing applications of green tea extract or compounds isolated from it also take part of this text.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20653541     DOI: 10.2174/2212798410901030203

Source DB:  PubMed          Journal:  Recent Pat Food Nutr Agric        ISSN: 1876-1429


  4 in total

1.  Cytocompatibility and Synergy of EGCG and Cationic Peptides Against Bacteria Related to Endodontic Infections, in Planktonic and Biofilm Conditions.

Authors:  Karina Sampaio Caiaffa; Vanessa Rodrigues Dos Santos; Gabriel Flores Abuna; Norival Alves Santos-Filho; Eduardo Maffud Cilli; Vivien Thiemy Sakai; Luciano Tavares Angelo Cintra; Cristiane Duque
Journal:  Probiotics Antimicrob Proteins       Date:  2021-08-16       Impact factor: 4.609

2.  Physiologically based pharmacokinetic modeling of tea catechin mixture in rats and humans.

Authors:  Francis C P Law; Meicun Yao; Hui-Chang Bi; Stephen Lam
Journal:  Pharmacol Res Perspect       Date:  2017-04-17

3.  Formulation and characterization of EGCG for the treatment of superficial bladder cancer.

Authors:  Katarzyna Dettlaff; Maciej Stawny; Magdalena Ogrodowczyk; Anna Jelińska; Waldemar Bednarski; Dorota Wątróbska-Świetlikowska; Rick W Keck; Omar A Khan; Ibrahim H Mostafa; Jerzy Jankun
Journal:  Int J Mol Med       Date:  2017-06-14       Impact factor: 4.101

4.  Bioavailability of Epigallocatechin Gallate Administered With Different Nutritional Strategies in Healthy Volunteers.

Authors:  Vicente Andreu-Fernández; Laura Almeida Toledano; Nieves Pizarro; Elisabet Navarro-Tapia; María Dolores Gómez-Roig; Rafael de la Torre; Óscar García-Algar
Journal:  Antioxidants (Basel)       Date:  2020-05-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.